Dr. Reddy’s gets USFDA observations for Srikakulam facility

17 Jun 2017 Evaluate

US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, on June 16, 2017. The pharma major has been issued a Form 483 with one observation, which it is addressing.

Recently, USFDA had completed audit of the company’s Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on May 25, 2017 with zero observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×